Supply Chain

Researchers at Johannes Gutenberg University of Mainz in Germany are conducting early human studies for a "universal cancer vaccine."

A growing number of med tech startups are entering the breast pump market, redesigning the device to improve comfort and convenience for women who breast-feed, according to ABC13.

Six health systems, all part of consortium AllSpire Health Partners, have formed a group purchasing organization.

 Global Healthcare Exchange, a company focused on healthcare supply chain management solutions, recently acquired Hap-X, a leader in automated payment management solutions.

Park City, Utah-based Distal Access created a new tissue resection device to easily remove uterine polyps.

Tesaro's experimental ovarian cancer drug niraparib proved to significantly lengthen progression-free survival time in patients during a recent Stage 3 trial.

Shire's experimental drug to treat attention-deficit hyperactive disorder showed positive results in a recent study, bringing the company one step closer to earning approval from the Food and Drug Administration.

Richard Padzur, MD, will head the Oncology Center of Excellence, a program created under Vice President Joe Biden's Cancer Moonshot initiative to accelerate cancer research.

The Food and Drug Administration denied Lipocine's New Drug Application for its oral testosterone drug.

The Food and Drug Administration should eliminate its approve/disapprove method of reviewing new drug applications and instead use a Consumer Reports approach that is based on drug ratings, according to a column in the Wall Street Journal by John Sotos,…